Guidance Tools and resources Information for the public Evidence History A list of downloadable documents created during development. Guidance published. Consultation comments and responses PDF 1.
The operation that you have selected will move away from the current results page, your download options will not persist. Filter results by. Evidence type Guidance and Policy
This guideline covers care and support for people with advanced stage 4 breast cancer. It aims to help them and their healthcare professionals make shared decisions about tests and treatments to improve outcomes and quality of life. This guideline covers diagnosing and managing early and locally advanced breast cancer.
Breast cancer is the most common cancer in women and the second most common cause of death from cancer in women in the United Kingdom. Each year in the UK more than 12 women and 70 men will die from advanced breast cancer having lived with this condition for an average of two to three years before death. Clinical practice and availability of certain treatments and procedures are known to vary across the UK.
All NICE products on breast cancer. Published products on this topic We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Thank you for visiting nature. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser or turn off compatibility mode in Internet Explorer.
The National Institute for Health and Care Excellence NICE has today published new draft recommendations for the diagnosis and management of early and locally advanced breast cancer. Early breast cancer is diagnosed when the cancer is only found in the breast and the lymph nodes nearby most often under the armand has not spread to other parts of the body, where it unfortunately becomes incurable. The draft guidelinewhich is open for public consultation until 6 March, offers a number of key updates on previous clinical recommendations published in These include the extension of aromatase inhibitor therapy for some women to further reduce the risk of recurrence, the use of bisphosphonates for a small group of patients to help prevent the disease spreading to the bone, and the recommendation that all women who are having a mastectomy be offered the choice of immediate breast reconstruction along with full information about all appropriate reconstructive surgery options.
People have the right to be involved in discussions and make informed decisions about their care, as described in your care. However, no discrimination is intended and recommendations relate to all those who have early or locally advanced breast cancer. Making decisions using NICE guidelines explains how we use words to show the strength or certainty of our recommendations, for example, we use 'offer' to reflect a strong recommendation, usually where there is clear evidence of benefit and we use 'consider' to reflect a recommendation for which the evidence of benefit is less certain.